Haoxi Health Technology Limited
HAOCommunication ServicesNASDAQAdvertising Agencies · Last scanned Jul 22, 2026
Scan Results
Daily timeframeHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. With a market capitalization of $1.5M, it sits in micro-cap territory. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms.
Market Cap
$1.5M
Beta
-1.46
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-16.36
EPS (Fwd)
—
ROE
-16.0%
ROA
-22.1%
Cash
$6.8M
Total Debt
$1.6M
Free CF
-$886,281
52W Change
-99.9%
Annual Financials
Cash vs Debt
Where HAO stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, HAO finished 99.73% below its 150-day moving average ($104.38) and 99.75% below its 200-day moving average ($113.16). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HAO overbought or oversold?
At the July 15, 2026 close, HAO's RSI(14) was 11.5, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $6.8M in cash and $1.6M in debt, HAO maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow is running at -$886K, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -16.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $12.8M (2021) to $48.5M (2024), reflecting a 278% increase over the period.
HAO's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Haoxi Health Technology Limited and its sector.